Clinical trial
Phase II Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon
NCT03087929 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon
- Lead sponsor
- Sunnybrook Health Sciences Centre
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 20, 2013
- Completion date
- March 15, 2017
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.